Artificial intelligence is appearing everywhere — in our phones, workplaces, cars and even the way healthcare is delivered.
But what does AI actually have to do with osteoporosis and broken bones? Quite a lot, as it turns out.
For many years, conversations around health, infrastructure, housing, transport, and community planning have focused mainly on children, youth, and working-age adults. These remain essential priorities, but there is another reality we can no longer ignore: more South Africans are growing older, and our communities must be ready to support them.
While osteoporosis is most commonly diagnosed later in life, the foundation for strong bones is built much earlier — during childhood and adolescence.
In recent years, medications used for weight management — particularly GLP-1 receptor agonists such as semaglutide and similar treatments — have received significant attention. What impact do these medications have on muscle and bone health?
Gender-affirming healthcare is essential for the well-being of transgender and gender-diverse individuals. As more people access gender-affirming hormone therapy (GAHT), it becomes increasingly important to understand how these treatments affect long-term health — including bone density, a critical aspect of overall health and mobility.
